Kim Julie So-Young insider trades
Kim Julie So-Young has filed 3 Form 4s with the SEC that we hold, all for Takeda Pharmaceutical Co LTD (TAK), as President and CEO, Director. Across all of them we count 0 purchases worth $0 and 1 sale worth $1.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($1.5M). The largest single trade was a sale of 89,090 shares of Takeda Pharmaceutical Co LTD worth $1.5M, dated 2026-08-10. The first filing on our record is dated 2026-04-28 and the latest 2026-08-12.
Takeda Pharmaceutical Co LTD (TAK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-10 | S, sale reported on Form 4 | 89,090 | $1.5M | 2026-08-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1977732) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms